Organovo Holdings: (OTC: ONVO)
$4.28
0.10 (2.29%)
Volume 66,295
May 24 11:17 AM ET
Zacks Rank: NA 
| |
Overview Quote
Stock Activity
| Day Low - High | 4.20 - 4.30 |
| 52wk Low - High | 1.49 - 10.90 |
| Previous Close | 4.18 |
| Avg. Volume | 708,631 |
| Industry | MED-BIOMED/GENE |
| Market Cap | 260.40 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | -0.02 |
| PE (Forward) | 0.00 |
| Current Year Est. | 0.00 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
|
Zacks Recommendation
|
NA |
Zacks Industry Rank
|
86 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | NA |
| Current Quarter Estimate | -0.05 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-14-2013 |
| EPS Last Year | NA |
| Expected Earnings Growth | NA |
Company Description
Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ANIKA THERAPEUT | ANIK | 14.03 | |
|
| GENTIUM SPA-ADR | GENT | 8.49 | |
|
| AASTROM BIOSCI | ASTM | 0.56 | |
|
| ACADIA PHARMA | ACAD | 13.79 | |
|
| ACHILLION PHARM | ACHN | 7.64 | |
|
| ADDEX THERA LTD | ADDXF | 6.62 | |
|
| AETERNA ZENTARS | AEZS | 2.03 | |
|
| AFFYMAX INC | AFFY | 1.40 | |
|
| ALEXION PHARMA | ALXN | 99.88 | |
|
| ALKERMES INC | ALKS | 33.00 | |
|
Sector:Medical>> Industry:MED-BIOMED/GENE
COMPARE TICKER vs. Its Peers
Financials
| EPS TTM | NA |
| Sales | 1 |
| Net Income | -44 |
| Price/Earnings | NA |
| Price/Book | NA |
| Price/Cash Flow | NA |
| Price/Sales | 217.55 |
News
LOTE, MJNA, ONVO added to Active OTC Stock Watch List at GSR - Accesswire-Tnw
Apr 30, 2013
Penny Stocks On The Move: (OTCQB: LOTE), (OTCQX: ONVO) - Accesswire-Tnw
Apr 29, 2013
Organovo to Present at the 12th Annual Needham Healthcare Conference - Pr Newswire
Apr 25, 2013
Organovo Describes First Fully Cellular 3D Bioprinted Liver Tissue - Pr Newswire
Apr 22, 2013
Organovo to Describe 3D Liver Assay at Experimental Biology Conference - Pr Newswire
Apr 10, 2013
Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com - Pr Newswire
Apr 8, 2013
Why I Finally Added 3D Systems to My Portfolio - TheMotleyFool
Apr 8, 2013
Organovo Holdings, Inc. Announces Change of Fiscal Year - Pr Newswire
Apr 3, 2013
Broker Recommendations
| Current ABR | 3.00 |
| ABR (Last Week) | 3.00 |
| # of recs in ABR | 1 |
| Average Target Price | 6.00 |
| Industry Rank by ABR | 86 out of 265 |
| Rank in Industry | NA |
